01 / EXTEND
GHRH-analog research
Literature describes CJC-1295's extended-action signalling at pituitary GHRH receptors.
GHRH + GHRP Combination · Research Compound
CJC
+ Ipamorelin.
A combined research peptide pairing a long-acting GHRH analog with a selective ghrelin-receptor agonist. Literature examines synergistic effects on pituitary GH-release pathways. Reference information only — not for human or animal consumption.
- Class
- GHRH + GHRP Combo
- Pathway
- Pituitary GH Release
- Route
- Subcutaneous
// 01About the compound
CJC-1295 is a long-acting GHRH-analog research peptide. Literature describes its extended-action signalling at the GHRH receptor compared with native GHRH.
Ipamorelin is a selective ghrelin-receptor (GHS-R) agonist research peptide. Research examines its GH-pulse signalling specificity relative to earlier-generation GHRPs.
The combined vial is included in the Max Nutrition USA catalog as one of the most-studied GHRH/GHRP combinations in current endogenous-GH research literature.
// 02Mechanism — what the literature describes
Two complementary signals to the pituitary — natural GH release without the bypass.
02 / TRIGGER
GHS-R research
Research examines Ipamorelin's selective GHS-R agonist signalling specificity.
03 / SYNERGY
Combined-pathway research
Combination research peptides examine synergistic GH-pulse signalling versus single-compound comparators.
04 / OUTCOMES
Downstream IGF-1 research
Literature examines downstream IGF-1 axis and tissue-signalling endpoints.
// 03Research focus areas
Endogenous-GH research
Studies examine endogenous GH-pulse pharmacology versus exogenous-GH literature.
Sleep-architecture research
GH-pulse pharmacology is examined for associations with slow-wave sleep dynamics.
Protein-synthesis research
GH-axis literature examines protein-synthesis and lean-mass endpoints.
Lipolysis research
Studies examine lipid-mobilisation endpoints under GH-axis activation.
Tissue-recovery research
Literature examines tissue-repair and post-stress recovery endpoints.
Comparator research
Endogenous GH-release pharmacology is examined alongside recombinant somatropin literature as a comparator.
// 04Related research compounds
GHRH-analog research
Tesamorelin
Stabilized GHRH-analog research peptide.
View page → Triple-agonist researchRetatrutide
Triple-agonist incretin research compound in current metabolic literature.
View page → Tissue-repair researchBPC-157 + TB-500
Connective-tissue and systemic-repair pathway research.
View page → Mitochondrial researchMOTS-C 40mg
Mitochondrial-derived peptide research; cellular-energy pathway literature.
View page →Research inquiries.
Direct line.
DM @max_nutritionusa for current CJC+Ipa stock, pricing, CoA requests, and shipping. By contacting us you affirm you are a qualified researcher and will use any compound purchased strictly for laboratory research — not for human or animal consumption. We do not provide dosing or medical advice.
Disclaimer — Research Use Only
All products offered by Max Nutrition USA are sold strictly for in vitro laboratory research purposes only. Not for human or animal consumption. Not for diagnostic, therapeutic, or veterinary use.
These compounds have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease. They are not approved drugs, dietary supplements, or cosmetics under the Federal Food, Drug, and Cosmetic Act.
All content on this site — including product names, mechanism descriptions, and references to scientific literature — is provided for educational and informational purposes only. Nothing on this site constitutes medical, pharmaceutical, or dosing advice. Always consult a qualified, licensed healthcare professional before considering any application involving these or any other compounds.
Buyer attestation. By submitting an inquiry or placing an order, you represent and warrant that you are a qualified professional or researcher of legal age in your jurisdiction; that you will use these products solely for in vitro laboratory research; that you will not administer, ingest, inject, or otherwise consume any product purchased; and that you will handle, store, and dispose of all materials in accordance with all applicable federal, state, and local laws and regulations.
Max Nutrition USA does not provide dosing, administration, protocol, or medical advice through any channel, including direct messages, email, or phone. Any informal use-related questions will be declined.
Max Nutrition USA assumes no liability for misuse, improper handling, or use outside of a controlled research setting. The purchaser assumes all risks and responsibilities associated with the use, storage, and handling of these products.